Abstracts tagged "fibromyalgia and guidelines"

Abstract Number: 918 • 2015 ACR/ARHP Annual Meeting
Assessment of the Temporal Variation of the Fibromyalgia Patient Profile Between 2005 and 2013: Do Guidelines Inform Clinical Care?
Angeliki Karellis^1,2, Emmanouil Rampakakis¹, Peter A. Ste-Marie³, Yoram Shir³, John S. Sampalis^1,4 and Mary-Ann Fitzcharles^3,5, ¹JSS Medical Research, St-Laurent, QC, Canada, ²Department of Surgery, McGill University, Montreal, QC, Canada, ³Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, QC, Canada, ⁴McGill University, Montreal, QC, Canada, ⁵Division of Rheumatology, McGill University Health Centre, Montreal, QC, Canada
Background/Purpose: In the last decade, interest in fibromyalgia (FM) has increased with the publication of revised diagnostic criteria and clinical guidelines. The 2010 and revised…
Abstract Number: 838 • 2013 ACR/ARHP Annual Meeting
Recommendations for the Classification and Diagnosis of Fibromyalgia Syndrome Provided By Independently Developed Evidence-Based Interdisciplinary Guidelines Spanning Three Continents
Mary-Ann Fitzcharles¹, Yoram Shir², Jacob N. Ablin³, Dan Buskila⁴, Howard Amital⁵, Peter Henningsen⁶ and Winfried Häuser⁷, ¹Rheumatology & Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, QC, Canada, ²Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, QC, Canada, ³Rheumatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, ⁴Ben-Gurion University, Beer-Sheva, Israel, ⁵Department of Medicine B, Center for Autoimmune Diseases, Sheba Medical Center, Tel-hashomer, Israel, ⁶Department Internal Medicine I, Klinikum Saarbrücken, Saarbrücken, Germany, ⁷Klinikum Saarbrücken, Saarbrücken, Germany
Background/Purpose: Fibromyalgia (FM), often disputed and challenged, has emerged as a clear cluster of symptoms and co-morbidities, characterized by subjective complaints without physical or biomarker…
Abstract Number: 118 • 2013 ACR/ARHP Annual Meeting
The Controversies and Points Of Debate That Remain a Challenge For Fibromyalgia Care
Mary-Ann Fitzcharles¹, Peter A. Ste-Marie², Don L. Goldenberg³, John X. Pereira⁴, Susan Abbey⁵, Manon Choinière⁶, Gordon Ko⁷, Dwight E. Moulin⁸, Pantelis Panopalis⁹, Johanne Proulx¹⁰ and Yoram Shir², ¹Rheumatology & Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, QC, Canada, ²Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, QC, Canada, ³Rheumatology, Newton-Wellesley Hosp, Newton, MA, ⁴University of Calgary, Calgary, AB, Canada, ⁵University of Toronto, Toronto, ON, Canada, Toronto, ON, Canada, ⁶University of Montreal, Montreal, QC, Canada, ⁷University of Toronto, Toronto, ON, Canada, ⁸University of Western Ontario, London, ON, Canada, ⁹Rheumatology, McGill University Health Centre, Montreal, QC, Canada, ¹⁰Patient Representative, Montreal, QC, Canada
Background/Purpose: Fibromyalgia (FM) continues to present challenges for the health care community, with perceptions of disease and attitudes of physicians being highly polarized. Neurophysiologic studies…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].